PROSTAGLANDINS & OTHER LIPID MEDIATORS

Scope & Guideline

Illuminating the Role of Lipids in Health and Disease

Introduction

Welcome to your portal for understanding PROSTAGLANDINS & OTHER LIPID MEDIATORS, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN1098-8823
PublisherELSEVIER SCIENCE INC
Support Open AccessNo
CountryUnited States
TypeJournal
Converge1996, from 1998 to 2024
AbbreviationPROSTAG OTH LIPID M / Prostaglandins Other Lipid Mediat.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressSTE 800, 230 PARK AVE, NEW YORK, NY 10169

Aims and Scopes

The journal 'Prostaglandins & Other Lipid Mediators' focuses on the multifaceted roles of lipid mediators in health and disease, emphasizing their biochemical pathways, physiological impacts, and potential therapeutic applications.
  1. Lipid Mediator Research:
    The journal publishes research on lipid mediators such as prostaglandins, leukotrienes, and resolvins, exploring their biosynthesis, signaling pathways, and roles in various physiological and pathological processes.
  2. Clinical Applications and Therapeutics:
    Research articles often investigate the therapeutic potential of lipid mediators and their analogs in treating inflammatory diseases, cancer, and metabolic disorders.
  3. Mechanisms of Inflammation and Resolution:
    The focus includes understanding the mechanisms by which lipid mediators contribute to inflammation and the resolution of inflammation, with implications for chronic diseases.
  4. Nutritional and Dietary Impacts:
    The journal covers studies on the effects of dietary components, such as omega-3 fatty acids and antioxidants, on lipid mediator profiles and their physiological outcomes.
  5. Innovative Research Methodologies:
    Methodological advancements in lipidomics, including mass spectrometry and bioinformatics approaches, are highlighted to enhance the understanding of lipid mediators in biological systems.
The journal has seen a rise in specific themes that reflect current trends in research related to lipid mediators, highlighting innovative areas of study and clinical relevance.
  1. Specialized Pro-resolving Mediators (SPMs):
    There is an increasing focus on specialized pro-resolving mediators, which are crucial for resolving inflammation and promoting tissue repair, reflecting growing interest in their therapeutic potential.
  2. Lipid Mediators in Neurological Disorders:
    Research exploring the role of lipid mediators in neurological conditions, including Alzheimer’s disease and neuroinflammation, has gained momentum, emphasizing their significance in brain health.
  3. Metabolic Disorders and Lipid Profiles:
    Studies investigating the relationship between lipid mediators and metabolic disorders, such as obesity and diabetes, are trending, showcasing their role in metabolic regulation and potential interventions.
  4. Bioinformatics and Lipidomics:
    The use of bioinformatics tools and lipidomics technologies to analyze lipid mediators and their complex interactions is emerging, facilitating deeper insights into their biological roles.
  5. Cancer and Lipid Mediators:
    An uptick in research exploring the interactions between lipid mediators and cancer biology, particularly in tumor progression and treatment responses, indicates a growing intersection between oncology and lipid research.

Declining or Waning

While certain themes have been prominent in the journal, others appear to be declining in frequency and emphasis, indicating a potential shift in focus among researchers.
  1. Traditional Herbal Remedies:
    Research on traditional herbal remedies and their lipid mediatory effects has decreased, suggesting a waning interest in this area compared to more mechanistic studies.
  2. Basic Biochemistry of Lipid Metabolism:
    The foundational studies on lipid metabolism without direct implications for health or disease seem to be less frequent, reflecting a shift towards more applied research.
  3. Non-specific Anti-inflammatory Agents:
    Studies focusing solely on non-specific anti-inflammatory agents without linking them to lipid mediators or specific pathways have seen reduced publication, indicating a preference for more targeted approaches.

Similar Journals

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Driving excellence in vascular research for a healthier tomorrow.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1079-5642Frequency: 12 issues/year

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, published by Lippincott Williams & Wilkins, is a leading journal in the field of cardiovascular medicine, dedicated to the advancement of research surrounding arterial diseases, thrombosis, and vascular biology. With an impressive impact factor indicative of its reach and influence, this journal occupies a prominent position in the Q1 category of cardiology, ranking 13th out of 387 in its field according to Scopus, placing it within the top 96th percentile among cardiovascular research journals. Since its inception in 1990, ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY has been pivotal in disseminating cutting-edge research that drives innovation and education in cardiovascular health. Although it does not operate under an open access model, the journal is a vital resource for researchers, clinicians, and students looking for high-quality, peer-reviewed articles that contribute to the understanding and treatment of cardiovascular and vascular disorders. Its commitment to rigorous scientific standards and its focus on impactful findings make it an essential publication for anyone dedicated to the field.

Antioxidants

Connecting researchers to the world of antioxidants.
Publisher: MDPIISSN: Frequency: 12 issues/year

Antioxidants is a premier open-access journal published by MDPI that has been actively contributing to the field of antioxidant research since its inception in 2012. Based in Switzerland, the journal holds a noteworthy impact factor indicative of its scholarly influence, particularly given its high rankings in various categories. As of 2023, it proudly sits in the Q1 quartile in Biochemistry, Clinical Biochemistry, Food Science, and Physiology, solidifying its status as a critical resource for innovative studies. With a strong focus on the roles of antioxidants across multiple disciplines—ranging from molecular biology to food science—this journal serves as a vital platform for researchers, professionals, and students aiming to advance knowledge in mitigating oxidative stress and enhancing health through dietary and therapeutic approaches. The open-access model guarantees wide accessibility, allowing for the dissemination of significant research findings globally, making it indispensable for anyone engaged in modern biochemical and physiological studies.

Genes & Diseases

Innovating solutions through genetic research and discovery.
Publisher: KEAI PUBLISHING LTDISSN: 2352-4820Frequency: 6 issues/year

Genes & Diseases, published by KEAI PUBLISHING LTD, is a premier open-access journal dedicated to advancing the fields of genetics, biochemistry, and molecular biology. Established in 2014 and headquartered in Beijing, China, this journal has quickly risen to prominence, securing a place in the prestigious Q1 quartile in Biochemistry and Genetics (clinical), as well as Q2 in Cell Biology and Q1 in Molecular Biology as of 2023. With a commitment to disseminating cutting-edge research, Genes & Diseases serves as a critical platform for researchers, professionals, and students alike, ensuring that high-quality scientific work is openly accessible to the global community. The journal's exceptional impact is underscored by its selective Scopus rankings, which reflect its influence and relevance in key scientific domains, making it an essential resource for those exploring the intersections of genetics and disease pathology.

ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY

Exploring the Interplay Between Physiology and Biochemistry
Publisher: TAYLOR & FRANCIS LTDISSN: 1381-3455Frequency: 5 issues/year

Archives of Physiology and Biochemistry, published by Taylor & Francis Ltd, is a renowned journal that has been pivotal in advancing knowledge and research in the fields of physiology and biochemistry since its inception. With an impact factor reflective of its significant contributions, this journal is categorized in Q2 in Medicine (miscellaneous) and Q3 in Physiology, underscoring its relevance and scholarly impact within the scientific community. The journal publishes original research articles, review papers, and innovative methodologies that explore the intricate relationships between physiological functions and biochemical processes. With its commitment to fostering scientific discourse, the Archives of Physiology and Biochemistry serves as an essential resource for researchers, professionals, and students alike, providing insights and evidence that drive forward the frontiers of medical and physiological science. The journal is accessible in both print and online formats, ensuring that critical research reaches a wide audience.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

Elevating Understanding of Lipid Mechanisms
Publisher: ELSEVIERISSN: 1388-1981Frequency: 12 issues/year

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, published by Elsevier, is a leading academic journal that focuses on advancing the field of lipid biology. With an ISSN of 1388-1981 and an E-ISSN of 1879-2618, this journal has established itself as an essential resource for researchers, professionals, and students interested in cell and molecular biology, particularly regarding lipid interactions and functions. The journal boasts an impressive impact factor, standing in the top quartiles of its categories—Q1 in Molecular Biology and Q2 in Cell Biology. As part of the vibrant academic landscape of the Netherlands, it supports both traditional and open access publication models, ensuring that vital research is accessible to a global audience. The converged years from 1998 to 2025 mark its sustained commitment to quality and relevance in the fast-evolving field of lipid research. With a strong ranking in Scopus and a percentile in the 80th range in both Molecular Biology and Cell Biology, this journal continues to be a pivotal platform for scholarly communication and innovation in lipid-related research.

Journal of Inflammation Research

Exploring Innovations in Immunology and Allergy Research
Publisher: DOVE MEDICAL PRESS LTDISSN: Frequency: 1 issue/year

Journal of Inflammation Research, published by Dove Medical Press Ltd, is a premier open-access journal dedicated to advancing the field of immunology and allergy, with a particular focus on the biological mechanisms underlying inflammation. Since its inception in 2008, this journal has provided a vital platform for researchers to share their findings and foster collaboration within the global scientific community. With an impressive 2023 impact factor placing it in the Q2 category for both Immunology and Immunology and Allergy, the journal has consistently maintained its relevance and high academic standards, ranking #100 in Medicine (Immunology and Allergy) and #118 in Immunology (Immunology and Microbiology) according to Scopus metrics. The E-ISSN 1178-7031 allows for easy access to a plethora of pioneering research articles, reviews, and clinical studies that address contemporary issues in inflammation and immunity. As a leading resource for researchers, professionals, and students alike, Journal of Inflammation Research is committed to facilitating the dissemination of groundbreaking discoveries that contribute to improved therapeutic strategies and health outcomes.

PPAR Research

Pioneering Discoveries in Pharmacology and PPAR Function
Publisher: HINDAWI LTDISSN: 1687-4757Frequency:

PPAR Research, an esteemed journal published by HINDAWI LTD, specializes in the rapidly evolving fields of drug discovery and pharmacology, contributing significantly to the body of research surrounding peroxisome proliferator-activated receptors (PPARs) and their roles in various biochemical processes. With an open access policy implemented since 2006, the journal ensures that its high-quality content is readily available, promoting widespread dissemination of knowledge. Currently ranked in the Q2 category for both Drug Discovery and Medical Pharmacology, it boasts a respectable position within the scientific community, evidenced by its Scopus rankings. PPAR Research serves as an essential resource for researchers, professionals, and students looking to advance their understanding of PPAR biology and its implications in therapeutic development. The journal's commitment to excellence and accessibility makes it a key player in supporting innovative research and critical discussions in the life sciences.

EUROPEAN JOURNAL OF LIPID SCIENCE AND TECHNOLOGY

Exploring the intersection of biochemistry and technology.
Publisher: WILEYISSN: 1438-7697Frequency: 12 issues/year

EUROPEAN JOURNAL OF LIPID SCIENCE AND TECHNOLOGY, published by WILEY, is a reputable academic journal dedicated to advancing the field of lipid science and technology. With an ISSN of 1438-7697 and E-ISSN 1438-9312, this journal serves as a critical resource for researchers, professionals, and students interested in the bioengineering, industrial applications, and nutritional science of lipids. Covering a broad spectrum from biochemistry to food science, it holds distinguished rankings across multiple categories, including Q2 in Chemistry and Food Science, and Q3 in Biotechnology, showcasing its significance in the interdisciplinary study of lipids. The journal welcomes Open Access options, fostering the dissemination of knowledge and innovation in lipid research. With converged years extending from 2000 to 2024, this journal remains at the forefront of lipid-related research, encouraging scholarly contributions that push the boundaries of science and technology.

BIOCHIMIE

Unveiling the Science Behind Life's Complexities
Publisher: ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIERISSN: 0300-9084Frequency: 12 issues/year

Welcome to BIOCHIMIE, a prestigious journal dedicated to advancing the field of biochemistry and related areas of medicine. Published by Elsevier France - Editions Scientifiques Medicales Elsevier, this journal has been a cornerstone of scientific communication since its inception in 1971 and will continue to contribute essential research until 2024. With an impressive impact factor and categorized in Q2 for Biochemistry and Q1 for Miscellaneous Medicine, BIOCHIMIE ranks among the top quartiles in its fields, underscoring its significance and influence in the scientific community. Targeting a wide audience of researchers, professionals, and students, the journal publishes high-quality articles that explore innovative research and developments in biochemistry, genetics, and molecular biology, reflected in its Scopus ranking of 136 out of 438 in the biochemistry category. Despite its traditional publication format, the journal remains committed to promoting impactful research that drives the future of biochemistry and molecular medicine, ensuring that readers have access to critical insights that foster advancements in health and science.

MAGNESIUM RESEARCH

Deepening Understanding of Magnesium's Biochemical Significance
Publisher: JOHN LIBBEY EUROTEXT LTDISSN: 0953-1424Frequency: 4 issues/year

MAGNESIUM RESEARCH, published by John Libbey Eurotext Ltd, is a leading journal in the fields of biochemistry, clinical biochemistry, and molecular biology, dedicated to advancing the understanding of magnesium's role in biological systems. With an ISSN of 0953-1424 and an E-ISSN of 1952-4021, this journal has been a vital resource for researchers and professionals since its inception in 1988, now converging into its 2024 issues. Positioned in the Q4 category for 2023 across several biochemistry domains, the journal is indexed in Scopus, providing a significant platform for the dissemination of research findings. Despite its current rankings reflecting a need for further impact, the journal serves as an important venue for emerging research that explores the biochemical and metabolic functions of magnesium, underlining its crucial influence on health and disease. Although primarily published using traditional access models, the content remains relevant for those seeking to deepen their knowledge in this essential mineral’s biological importance. Researchers, students, and professionals in related fields will find MAGNESIUM RESEARCH an invaluable addition to their academic resources.